Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative indocyanine green fluorescence angiography in colorectal surgery to prevent anastomotic leakage (FRENCH-GRECCAR)
2021-004814-21Phase 3Active
- Sponsor
- CHU de Besançon
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of indocyanine green in colorectal cancer (CRC) (2 arms), sponsored by CHU de Besançon. Primary endpoint: Anastomotic leakage within 90 days. Started Mar 2022; status: active.
02
Drugs
indocyanine green
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2021-004814-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-004814-21.